Repligen
RGEN
441 hedge funds and large institutions have $9.02B invested in Repligen in 2022 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 158 increasing their positions, 140 reducing their positions, and 62 closing their positions.
66% more call options, than puts
Call options by funds: $83.9M | Put options by funds: $50.6M
23% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 62
13% more repeat investments, than reductions
Existing positions increased: 158 | Existing positions reduced: 140
3.95% more ownership
Funds ownership: 91.97% → 95.92% (+4%)
2% more funds holding
Funds holding: 434 → 441 (+7)
6% less capital invested
Capital invested by funds: $9.56B → $9.02B (-$538M)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$256M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$153M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$48.5M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$44.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$37.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$102M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$52.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$50.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$40.4M |
| 5 |
AI
Axiom Investors
Greenwich,
Connecticut
|
-$30.8M |
RGEN Hedge Fund Activity: Q4 2022 in Review
441 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q4 2022, worth a combined $9.02B — down 5.6% from $9.56B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new RGEN positions and 62 closed out — a net gain of 14 holders — while 158 added to existing stakes and 140 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $256M. The largest seller was 1832 Asset Management, exiting entirely with an estimated $102M sold.
- 441 institutional investors held Repligen (RGEN) as of Q4 2022, up from 434 in Q3 2022.
- Funds reported $9.02B of Repligen stock for Q4 2022, down 5.6% quarter-over-quarter.
- 76 funds opened new Repligen positions in Q4 2022 and 62 closed out, a net change of +14 holders.
- The largest Repligen buyer in Q4 2022 was T. Rowe Price Associates, an estimated $256M added.
- The largest Repligen seller in Q4 2022 was 1832 Asset Management, an estimated $102M sold.
Based on aggregated 13F filings for Q4 2022.